Clinical trial
Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients
NCT00429247 · University Hospital of Crete, Other · Completed
Key facts
| NCT number | NCT00429247 |
|---|---|
| Title | Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients |
| Official title | A Pilot Randomized Phase II Study of Adjuvant Administration of Trastuzumab (HERCEPTIN) Versus Observation After the Completion of Adjuvant Chemotherapy and Radiotherapy in Patients With Stage I-III Breast Cancer Who Have Detectable Disseminated and/or Circulating Tumor Cells (DTCs and/or CTCs) in… |
| Lead sponsor | University Hospital of Crete, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Trastuzumab |
| Enrollment | 75 |
| Start date | Feb 1, 2003 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jan 31, 2007 |
| Last update posted | Jul 21, 2011 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: